Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of August 2026

  1. Butterfly Network Inc.

    World Rank (Aug-2026)
    5,787
    Market Cap (Aug-2026)
    2.354 Billion USD
    World Rank (Jan-05-2024)
    17,614
    Market Cap (Jan-05-2024)
    0.211 Billion USD
    World Rank (Jul-30-2023)
    12,915
    Market Cap (Jul-30-2023)
    0.487 Billion USD
    World Rank (Dec-25-2022)
    12,766
    Market Cap (Dec-25-2022)
    0.473 Billion USD
    World Rank (Jan-07-2022)
    8,478
    Market Cap (Jan-07-2022)
    1.20 Billion USD
    Annual Revenue in USD
    98 Million USD
    Annual Operating Income in USD
    -86 Million USD
    Annual Net Income in USD
    -77 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  2. CareDx Inc.

    World Rank (Aug-2026)
    5,798
    Market Cap (Aug-2026)
    2.345 Billion USD
    World Rank (Jan-05-2024)
    11,463
    Market Cap (Jan-05-2024)
    0.602 Billion USD
    World Rank (Jul-30-2023)
    11,590
    Market Cap (Jul-30-2023)
    0.600 Billion USD
    World Rank (Dec-25-2022)
    11,241
    Market Cap (Dec-25-2022)
    0.603 Billion USD
    World Rank (Jan-07-2022)
    6,174
    Market Cap (Jan-07-2022)
    2.06 Billion USD
    Annual Revenue in USD
    380 Million USD
    Annual Operating Income in USD
    -31 Million USD
    Annual Net Income in USD
    -21 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Caredx is a partner for transplant patients and the Transplant Ecosystem. The company products are Kidney Transplant, Heart Transplant, Lab Products, Digital and Remotrac. The headquarters is in USA.
  3. Dentsply Sirona

    World Rank (Aug-2026)
    5,844
    Market Cap (Aug-2026)
    2.311 Billion USD
    World Rank (Jan-05-2024)
    2,103
    Market Cap (Jan-05-2024)
    7.559 Billion USD
    World Rank (Jul-30-2023)
    1,882
    Market Cap (Jul-30-2023)
    8.718 Billion USD
    World Rank (Dec-25-2022)
    2,079
    Market Cap (Dec-25-2022)
    6.841 Billion USD
    World Rank (Jan-07-2022)
    1,590
    Market Cap (Jan-07-2022)
    12.33 Billion USD
    Annual Revenue in USD
    3,680 Million USD
    Annual Operating Income in USD
    -422 Million USD
    Annual Net Income in USD
    -598 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    DENTSPLY SIRONA manufactures Medical devices related to dental equipment. Headquarters is in Pennsylvania, USA.

  4. Vera Therapeutics Inc.

    World Rank (Aug-2026)
    5,905
    Market Cap (Aug-2026)
    2.279 Billion USD
    World Rank (Jan-05-2024)
    10,674
    Market Cap (Jan-05-2024)
    0.689 Billion USD
    World Rank (Jul-30-2023)
    10,207
    Market Cap (Jul-30-2023)
    0.761 Billion USD
    World Rank (Dec-25-2022)
    11,799
    Market Cap (Dec-25-2022)
    0.550 Billion USD
    World Rank (Jan-07-2022)
    14,196
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Annual Operating Income in USD
    -315 Million USD
    Annual Net Income in USD
    -300 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  5. Mineralys Therapeutics Inc.

    World Rank (Aug-2026)
    5,921
    Market Cap (Aug-2026)
    2.267 Billion USD
    World Rank (Jan-05-2024)
    14,697
    Market Cap (Jan-05-2024)
    0.355 Billion USD
    World Rank (Jul-30-2023)
    14,411
    Market Cap (Jul-30-2023)
    0.382 Billion USD
    Annual Operating Income in USD
    -171 Million USD
    Annual Net Income in USD
    -155 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  6. Vericel Corporation

    World Rank (Aug-2026)
    5,928
    Market Cap (Aug-2026)
    2.263 Billion USD
    World Rank (Jan-05-2024)
    6,459
    Market Cap (Jan-05-2024)
    1.623 Billion USD
    World Rank (Jul-30-2023)
    6,143
    Market Cap (Jul-30-2023)
    1.797 Billion USD
    World Rank (Dec-25-2022)
    7,816
    Market Cap (Dec-25-2022)
    1.125 Billion USD
    World Rank (Jan-07-2022)
    6,909
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    276 Million USD
    Annual Operating Income in USD
    11 Million USD
    Annual Net Income in USD
    17 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Bio pharmaceutical company with headquarters is in USA.
  7. Atricure

    World Rank (Aug-2026)
    5,942
    Market Cap (Aug-2026)
    2.253 Billion USD
    World Rank (Jan-05-2024)
    6,527
    Market Cap (Jan-05-2024)
    1.597 Billion USD
    World Rank (Jul-30-2023)
    4,782
    Market Cap (Jul-30-2023)
    2.615 Billion USD
    World Rank (Dec-25-2022)
    5,394
    Market Cap (Dec-25-2022)
    2.032 Billion USD
    World Rank (Jan-07-2022)
    5,055
    Market Cap (Jan-07-2022)
    2.83 Billion USD
    Annual Revenue in USD
    535 Million USD
    Annual Operating Income in USD
    -9 Million USD
    Annual Net Income in USD
    -11 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    AtriCure Provides Innovative Atrial Fibrillation Solutions company and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best in class solutions that can treat even the most complex cases. It served over 3,50,000 patients with ablation, over 2,500 healthcare professionals trained, products sold in over 50 countries and more than 700 employees worldwide. The headquarters is in USA.
  8. Harmony Biosciences Holdings Inc.

    World Rank (Aug-2026)
    5,989
    Market Cap (Aug-2026)
    2.220 Billion USD
    World Rank (Jan-05-2024)
    5,928
    Market Cap (Jan-05-2024)
    1.871 Billion USD
    World Rank (Jul-30-2023)
    5,534
    Market Cap (Jul-30-2023)
    2.111 Billion USD
    World Rank (Dec-25-2022)
    3,759
    Market Cap (Dec-25-2022)
    3.363 Billion USD
    World Rank (Jan-07-2022)
    5,877
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    868 Million USD
    Annual Operating Income in USD
    208 Million USD
    Annual Net Income in USD
    159 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

    Facts About Company

    The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

  9. Biohaven Pharmaceutical Holding Company

    World Rank (Aug-2026)
    6,000
    Market Cap (Aug-2026)
    2.211 Billion USD
    World Rank (Jan-05-2024)
    3,972
    Market Cap (Jan-05-2024)
    3.399 Billion USD
    World Rank (Jul-30-2023)
    7,470
    Market Cap (Jul-30-2023)
    1.300 Billion USD
    World Rank (Dec-25-2022)
    8,706
    Market Cap (Dec-25-2022)
    0.934 Billion USD
    World Rank (Jan-07-2022)
    2,147
    Market Cap (Jan-07-2022)
    8.44 Billion USD
    Annual Revenue in USD
    463 Million USD
    Annual Operating Income in USD
    -704 Million USD
    Annual Net Income in USD
    -847 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    Company Profile

    Biohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.

  10. Ocular Therapeutix

    World Rank (Aug-2026)
    6,015
    Market Cap (Aug-2026)
    2.205 Billion USD
    World Rank (Jan-05-2024)
    12,314
    Market Cap (Jan-05-2024)
    0.523 Billion USD
    World Rank (Jul-30-2023)
    14,969
    Market Cap (Jul-30-2023)
    0.350 Billion USD
    World Rank (Dec-25-2022)
    17,875
    Market Cap (Dec-25-2022)
    0.206 Billion USD
    World Rank (Jan-07-2022)
    13,549
    Market Cap (Jan-07-2022)
    0.49 Billion USD
    Annual Revenue in USD
    52 Million USD
    Annual Operating Income in USD
    -270 Million USD
    Annual Net Income in USD
    -266 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Ocular Therapeutix is a Biopharmaceutical Platform company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel based formulation technology. The company annual revenue is 12.3 million USD and 167 employees as on 2019. The headquarters is in USA.

Share

Ads